A decade ago, the isolation of tumorigenic breast cancer cells with the phenotype CD44+CD24−/low represented a first step towards the characterization of breast CSCs [14], which was complemented soon after with the discovery of their capacity to grow as mammospheres [69] and their enhanced aldehyde dehydrogenase activity [13]. The gene discussed is CD44; the disease is breast carcinoma.